COMMODORE CAPITAL LP's portfolio and holdings - Jul 2025

As per corporate shareholdings filed for Jun-2025, people matching COMMODORE CAPITAL LP publicly holds 36 stocks with a net worth of over US$ 1.7 B.

These are shares held by COMMODORE CAPITAL LP as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Month Ending
Add Superstar Alert
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Aeglea BioTherapeutics Inc Commodore Capital Lp 16.58 116,324 0.32% 0.00 1.9 M
Ambrx Biopharma Inc - ADR Commodore Capital Lp 0.00 3,175,000 5.12% 0.00 -
Alpine Immune Sciences Inc Commodore Capital Lp 7.80 1,610,000 2.46% 0.00 12.6 M
Harpoon Therapeutics Inc Commodore Capital Lp 23.01 1,500,000 7.01% 0.00 34.5 M
RayzeBio Inc. Commodore Capital Lp 62.49 383,638 0.64% 0.00 24.0 M
Agios Pharmaceuticals Inc Commodore Capital Lp 39.27 2,325,000 4.00% 0.24 91.3 M
Alkermes plc Commodore Capital Lp 29.25 2,450,000 1.48% 0.30 71.7 M
Apogee Therapeutics Inc. Commodore Capital Lp 37.79 290,000 0.49% 0.00 11.0 M
Avalo Therapeutics Inc Commodore Capital Lp 9.65 483,000 4.46% 0.00 4.7 M
Cidara Therapeutics Inc Commodore Capital Lp 65.39 1,175,000 5.06% NEW 76.8 M
Celldex Therapeutics Inc. Commodore Capital Lp 22.60 3,450,000 5.20% 0.38 78.0 M
Centessa Pharmaceuticals plc - ADR Commodore Capital Lp 16.65 3,298,289 2.46% 0.70 54.9 M
Cogent Biosciences Inc Commodore Capital Lp 12.37 2,311,164 1.66% -4.72 28.6 M
CytomX Therapeutics Inc Commodore Capital Lp 2.07 7,692,300 4.66% NEW 15.9 M
Bright Minds Biosciences Inc Commodore Capital Lp 43.36 500,000 7.06% 0.00 21.7 M
Enliven Therapeutics Inc Commodore Capital Lp 20.68 4,692,809 7.92% 0.03 97.0 M
Inhibikase Therapeutics Inc Commodore Capital Lp 1.79 5,397,488 7.24% 0.05 9.7 M
Kymera Therapeutics Inc Commodore Capital Lp 42.26 750,000 1.06% NEW 31.7 M
Mind Medicine Inc Commodore Capital Lp 9.85 5,000,000 6.57% 0.62 49.3 M
Merus N.V Commodore Capital Lp 67.28 3,525,000 4.66% -1.25 237.2 M
Neurogene Inc Commodore Capital Lp 19.70 427,866 3.00% -3.48 8.4 M
Nurix Therapeutics Inc Commodore Capital Lp 9.55 3,948,653 5.17% -0.04 37.7 M
Nuvalent Inc - Ordinary Shares - Class A Commodore Capital Lp 76.13 1,375,000 1.91% -0.67 104.7 M
Oruka Therapeutics Inc. Commodore Capital Lp 15.18 1,419,714 3.79% 0.00 21.6 M
Perceptive Capital Solutions Corp - Ordinary Shares - Class A Commodore Capital Lp 10.54 750,000 6.78% 0.00 7.9 M
Protagonist Therapeutics Inc Commodore Capital Lp 61.43 1,075,000 1.73% NEW 66.0 M
Relay Therapeutics Inc Commodore Capital Lp 3.57 13,350,000 7.78% NEW 47.7 M
Soleno Therapeutics Inc Commodore Capital Lp 67.68 610,000 1.15% -1.02 41.3 M
Scholar Rock Holding Corp Commodore Capital Lp 34.47 1,450,000 1.51% -0.31 50.0 M
Spyre Therapeutics Inc. Commodore Capital Lp 17.14 1,988,084 3.29% 0.00 34.1 M
Tango Therapeutics Inc Commodore Capital Lp 6.90 1,500,000 1.35% NEW 10.4 M
Tyra Biosciences Inc Commodore Capital Lp 12.88 3,100,000 5.82% 4.04 39.9 M
Vera Therapeutics Inc - Ordinary Shares - Class A Commodore Capital Lp 22.02 800,000 1.25% -2.76 17.6 M
Viridian Therapeutics Inc Commodore Capital Lp 18.56 4,875,000 5.97% 1.56 90.5 M
VistaGen Therapeutics Inc Commodore Capital Lp 3.18 1,575,000 5.27% 0.00 5.0 M
Xenon Pharmaceuticals Inc Commodore Capital Lp 38.87 3,025,000 3.93% 0.91 117.6 M
Vaxcyte Inc 30.55 - Investor holds below 1%
ORIC Pharmaceuticals Inc 10.26 - Investor holds below 1%
Solid Biosciences Inc 5.62 - Investor holds below 1%
Cardiff Oncology Inc 2.17 - Investor holds below 1%
Celcuity Inc 49.96 - Investor holds below 1%
View All The Superstar Shareholder Portfolios